Sequana Medical N.V.
SEQUA.BR · BRU
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | – | -100% | -67.8% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | -€0 | -€0 | €0 | €0 |
| % Margin | – | – | 75.3% | 76.9% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €0 | €0 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | – | – | -9,229.3% | -4,291.1% |
| Other Income/Exp. Net | -€0 | -€0 | -€0 | -€0 |
| Pre-Tax Income | -€0 | -€0 | -€0 | -€0 |
| Tax Expense | €0 | €0 | €0 | €0 |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | – | – | -10,502.3% | -4,908.4% |
| EPS | -0.48 | -0.82 | -0.34 | -0.58 |
| % Growth | 41.5% | -141.2% | 41.4% | – |
| EPS Diluted | -0.48 | -0.82 | -0.34 | -0.58 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | – | – | -8,960.7% | -4,226.8% |